Literature DB >> 24277718

Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks.

Farooq Husain Maniyar1, Till Sprenger, Teshamae Monteith, Christoph Schankin, Peter James Goadsby.   

Abstract

Our aim was identify brain areas involved in the premonitory phase of migraine using functional neuroimaging. To this end, we performed positron emission tomography scans with H2(15)O to measure cerebral blood flow as a marker of neuronal activity. We conducted positron emission tomography scans at baseline, in the premonitory phase without pain and during migraine headache in eight patients. We used glyceryl trinitrate (nitroglycerin) to trigger premonitory symptoms and migraine headache in patients with episodic migraine without aura who habitually experienced premonitory symptoms during spontaneous attacks. The main outcome was comparing the first premonitory scans in all patients to baseline scans in all patients. We found activations in the posterolateral hypothalamus, midbrain tegmental area, periaqueductal grey, dorsal pons and various cortical areas including occipital, temporal and prefrontal cortex. Brain activations, in particular of the hypothalamus, seen in the premonitory phase of glyceryl trinitrate-triggered migraine attacks can explain many of the premonitory symptoms and may provide some insight into why migraine is commonly activated by a change in homeostasis.

Entities:  

Keywords:  PET; hypothalamus; migraine; periaqueductal grey; premonitory

Mesh:

Substances:

Year:  2013        PMID: 24277718     DOI: 10.1093/brain/awt320

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  109 in total

1.  Decade in review-migraine: incredible progress for an era of better migraine care.

Authors:  Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2015-10-27       Impact factor: 42.937

Review 2.  The Insula: A "Hub of Activity" in Migraine.

Authors:  David Borsook; Rosanna Veggeberg; Nathalie Erpelding; Ronald Borra; Clas Linnman; Rami Burstein; Lino Becerra
Journal:  Neuroscientist       Date:  2015-08-19       Impact factor: 7.519

Review 3.  Nutraceuticals and Behavioral Therapy for Headache.

Authors:  Rebecca Barmherzig; Thilinie Rajapakse
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

4.  Hypothalamic regulation of headache and migraine.

Authors:  Arne May; Rami Burstein
Journal:  Cephalalgia       Date:  2019-08-29       Impact factor: 6.292

Review 5.  Migraine: multiple processes, complex pathophysiology.

Authors:  Rami Burstein; Rodrigo Noseda; David Borsook
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

6.  New targets for migraine therapy.

Authors:  Amy R Tso; Peter J Goadsby
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

7.  Visual Field Losses in Patients with Migraine without Aura and Tension-Type Headache.

Authors:  Arif Ü Yener; Osman Korucu
Journal:  Neuroophthalmology       Date:  2017-01-11

Review 8.  ASICs as therapeutic targets for migraine.

Authors:  Greg Dussor
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

Review 9.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 10.  Cerebral hemodynamics in the different phases of migraine and cluster headache.

Authors:  Jakob M Hansen; Christoph J Schankin
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-31       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.